Single-dose ceftriaxone for chancroid

dc.contributor.author	Bowmer MI
dc.contributor.author	Nsanze H
dc.contributor.author	D'Costa LJ
dc.contributor.author	Dylewski J
dc.contributor.author	Fransen L
dc.contributor.author	Piot P
dc.contributor.author	Ronald AR
dc.date.accessioned	2013-06-11T06:45:16Z
dc.date.available	2013-06-11T06:45:16Z
dc.date.issued	1987-01
dc.identifier.citation	Antimicrob Agents Chemother. 1987 Jan;31(1):67-9.	en
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pubmed/3566241
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/31119
dc.description.abstract	Men with genital ulcers that were culture positive for Haemophilus ducreyi were treated with intramuscular ceftriaxone and randomized to three different dose regimens. All but 1 of 50 men treated with 1 g of intramuscular ceftriaxone were cured. Similarly, 0.5 and 0.25 g cured 43 of 44 men and 37 of 38 men, respectively. A single dose of 250 mg of intramuscular ceftriaxone is an effective treatment for chancroid.	en
dc.language.iso	en	en
dc.publisher	University of Nairobi	en
dc.title	Single-dose ceftriaxone for chancroid	en
dc.type	Article	en
local.publisher	Department of Medicine	en